Related Articles
Ibrutinib in CLL/SLL: From bench to bedside (Review)
Identification of glutathione S‑transferase π 1 as a prognostic proteomic biomarker for multiple myeloma using proteomic profiling
Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis
A unique MUC1-2-VNTR DNA vaccine suppresses tumor growth and prolongs survival in a murine multiple myeloma model
Secondary lymphoblastic leukemia occurring 38 months after the primary diagnosis of multiple myeloma: A case report